Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast (DCIS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03002766|
Recruitment Status : Completed
First Posted : December 26, 2016
Last Update Posted : December 26, 2016
By this non-randomized prospective study, it's evaluated the outcome of patients underwent BCS for DCIS at whom an established score system to address adjuvant therapies have been prospectively applied, according to the wideness of free margins.
Between March 2000 and April 2006, 224 patients were enrolled and followed within the study.
|Condition or disease||Intervention/treatment||Phase|
|Carcinoma Breast||Procedure: Breast conservative surgery||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||224 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast.|
|Study Start Date :||March 2000|
|Actual Primary Completion Date :||April 2006|
|Actual Study Completion Date :||April 2006|
- Ipsilateral Breast Tumor Recurrence (IBTR) [ Time Frame: six years ]
- Contralateral breast cancer (CBC) [ Time Frame: six years ]the side effects of radiotherapy may outweigh the reduction in the risk of IBTR
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03002766
|Milano, MI, Italy, 20133|
|Principal Investigator:||Massimiliano Gennaro, MD||Fondazione IRCCS Istituto Nazionale Tumori|